About this trial
The goal of this study is to explore whether health-related quality of life (HRQoL) can be used as a predictive indicator for lung cancer patients and to implement clinical interventions. The study addresses two main objectives:
Analyzing HRQoL data of lung cancer patients undergoing immunotherapy using machine learning clustering methods to explore data patterns and build an HRQoL early warning model (already developed).
Validating this HRQoL early warning model in real-world settings by classifying patients with different HRQoL characteristics and assessing the clinical value of the model
Eligibility criteria
Qualifiers
Histologically diagnosed with lung cancer
Age over 18 years
Currently receiving immunotherapy for lung cancer
Good verbal communication ability
Disqualifiers
Cognitive impairment or mental illness
Other severe diseases
Trial design
Treatments tested in this trial
- Symptom cluster-based care intervention
- Conventional care intervention
Treatment groups
Locations
Sponsors and collaborators
Second Affiliated Hospital of Zunyi Medical University
Lead sponsor
Ministry of Education of the People's Republic of China, Department of Humanities and Social Sciences
Collaborator